<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Virol J</journal-id><journal-id journal-id-type="iso-abbrev">Virol. J</journal-id><journal-title-group><journal-title>Virology Journal</journal-title></journal-title-group><issn pub-type="epub">1743-422X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">6998849</article-id><article-id pub-id-type="publisher-id">1288</article-id><article-id pub-id-type="doi">10.1186/s12985-020-1288-4</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Porcine &#x003b2;-defensin 2 inhibits proliferation of pseudorabies virus in vitro and in transgenic mice</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Huang</surname><given-names>Jing</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Qi</surname><given-names>Yanhua</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Antian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Chao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Xiao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Xi</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Li</surname><given-names>Lu</given-names></name><address><email>lilu@mail.hzau.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhou</surname><given-names>Rui</given-names></name><address><email>rzhou@mail.hzau.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1790 4137</institution-id><institution-id institution-id-type="GRID">grid.35155.37</institution-id><institution>State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, </institution><institution>Huazhong Agricultural University, </institution></institution-wrap>Wuhan, 430070 China </aff><aff id="Aff2"><label>2</label>Key Laboratory of Preventive Veterinary Medicine in Hubei Province, Cooperative Innovation Center for Sustainable Pig Production, Wuhan, 430070 China </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.410597.e</institution-id><institution>Chongqing Academy of Animal Sciences, </institution></institution-wrap>Chongqing, 402460 China </aff><aff id="Aff4"><label>4</label>Key Laboratory of Development of Veterinary Diagnostic Products, Ministry of Agriculture and Rural Affairs of the People&#x02019;s Republic of China, Wuhan, 430070 China </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.424020.0</institution-id><institution>International Research Center for Animal Disease, Ministry of Science and Technology of the People&#x02019;s Republic of China, </institution></institution-wrap>Wuhan, 430070 China </aff></contrib-group><pub-date pub-type="epub"><day>3</day><month>2</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>3</day><month>2</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>17</volume><elocation-id>18</elocation-id><history><date date-type="received"><day>16</day><month>10</month><year>2019</year></date><date date-type="accepted"><day>20</day><month>1</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s). 2020</copyright-statement><license license-type="OpenAccess"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Porcine &#x003b2;-defensin 2 (PBD-2), produced by host cells, is an antimicrobial cysteine-rich cationic peptide with multi-functions. Previous studies have demonstrated that PBD-2 can kill various bacteria, regulate host immune responses and promote growth of piglets. However, the antiviral role of PBD-2 is rarely investigated. This study aimed to reveal the antiviral ability of PBD-2 against pseudorabies virus (PRV), the causative pathogen of Aujeszky&#x02019;s disease, in PK-15 cells and in a PBD-2 expressing transgenic (TG) mouse model.</p></sec><sec><title>Methods</title><p id="Par2">In this study, the cytotoxicity of PBD-2 on PK-15 cells was measured by CCK-8 assay. PK-15 cells were incubated with PRV pre-treated with different concentrations of PBD-2 and PRV titers in cell culture supernatants were determined by real-time quantitative PCR (RT-qPCR). TG mice and wild-type (WT) mice were intraperitoneally injected with PRV and the survival rate was recorded for 10&#x02009;days. Meanwhile, tissue lesions in brain, spleen and liver of infected mice were observed and the viral loads of PRV in brain, liver and lung were analyzed by RT-qPCR.</p></sec><sec><title>Results</title><p id="Par3">PBD-2 at a maximum concentration of 80&#x02009;&#x003bc;g/mL displayed no significant cytotoxicity on PK-15 cells. A threshold concentration of PBD-2 at 40&#x02009;&#x003bc;g/mL was required to inhibit PRV proliferation in PK-15 cells. The survival rate in PBD-2 TG mice was 50% higher than that of WT mice. In addition, TG mice showed alleviated tissue lesions in brain, spleen and liver compared with their WT littermates after PRV challenge, while viral loads of PRV in brain, liver and lung of TG mice were significantly lower than that of WT mice.</p></sec><sec><title>Conclusions</title><p id="Par4">PBD-2 could inhibit PRV proliferation in PK-15 cells and protect mice from PRV infection, which confirmed the antiviral ability of PBD-2 both in vitro and in vivo. The application of PBD-2 in developing anti-viral drugs or disease-resistant animals can be further investigated.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Porcine &#x003b2;-defensin 2</kwd><kwd>Pseudorabies virus</kwd><kwd>Antiviral ability</kwd><kwd>Transgenic mice</kwd></kwd-group><funding-group><award-group><funding-source><institution>National Transgenic Project of China</institution></funding-source><award-id>2016ZX08006003-004</award-id><principal-award-recipient><name><surname>Li</surname><given-names>Lu</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Key Technologies Research and Development Program (CN)</institution></funding-source><award-id>2017YFD0500201</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Rui</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>Hubei Province Natural Science Foundation for Innovative Research Groups (CN)</institution></funding-source><award-id>2016CFA015</award-id><principal-award-recipient><name><surname>Zhou</surname><given-names>Rui</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2020</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par19">Defensins are a group of cationic microbicidal peptides, which are constituted of 18&#x02013;45 amino acids with three intramolecular disulfide bonds formed between pairs of conserved cysteine residues [<xref ref-type="bibr" rid="CR1">1</xref>]. Defensins in vertebrates are subdivided into &#x003b1;, &#x003b2; and &#x003b8; defensins based on their spatial structure and disulfide connectivity [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Within pigs, &#x003b2; defensin is the only subfamily of defensins which has been characterized so far [<xref ref-type="bibr" rid="CR4">4</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. Porcine &#x003b2;-defensin 2 (PBD-2) was first determined by sequence alignment with the existing sequence of porcine &#x003b2;-defensin 1 [<xref ref-type="bibr" rid="CR6">6</xref>]. It was further identified that PBD-2 was distributed in different pig tissues using a polyclonal antibody against PBD-2 [<xref ref-type="bibr" rid="CR7">7</xref>]. The antimicrobial activity of PBD-2 against gram-positive and gram-negative bacteria has been well described [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>]. PBD-2 also exhibited immunomodulatory properties [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Our recent research demonstrated that PBD-2 could alleviate inflammation through interacting with toll-like receptor 4 and suppressing the downstream NF-&#x003ba;B signaling pathway [<xref ref-type="bibr" rid="CR13">13</xref>]. Additionally, it has been found that PBD-2 can attenuate proliferation of porcine reproductive and respiratory syndrome virus (PRRSV) in MA-104 cells [<xref ref-type="bibr" rid="CR8">8</xref>]. Molecular docking evaluation has revealed that peptides derived from PBD-2 have the potential to be used to inhibit hepatitis E virus by interacting with its capsid protein [<xref ref-type="bibr" rid="CR14">14</xref>]. However, the effect of PBD-2 on virus proliferation in vivo remains unknown.</p><p id="Par20">Pseudorabies virus (PRV), an enveloped double-stranded DNA herpesvirus, is the etiological pathogen of Aujeszky&#x02019;s disease causing meningoencephalitis and paravertebral ganglioneuritis in pigs [<xref ref-type="bibr" rid="CR15">15</xref>]. The Bartha-k61 vaccine was brought to China from Hungary in the 1970s to prevent PRV infection, which has led to the successful control of PRV since 1980s [<xref ref-type="bibr" rid="CR16">16</xref>]. However, PRV variants in Bartha-K61-vaccinated pigs have resulted in resurgence of PRV prevalence in China since late 2011 [<xref ref-type="bibr" rid="CR17">17</xref>]. In China, with the infection rate being 13.14% in 2016, it still requires more efforts to achieve eradication of PRV [<xref ref-type="bibr" rid="CR18">18</xref>]. In addition to vaccination development, studies on novel strategies to combat PRV are also of great significance.</p><p id="Par21">On the basis of amino acid sequence alignment and molecular biological analyses, PRV resembles other alphaherpesviruses within the family <italic>Alphaherpesvirinae</italic> [<xref ref-type="bibr" rid="CR15">15</xref>]. The antiviral abilities of defensins against alphaherpesviruses have been described previously. Some &#x003b1;-defensins with antiviral ability against herpes simplex virus (HSV) infection were characterized, such as human neutrophil peptide (HNP) 1&#x02013;4, human &#x003b1;-defensin (HD) 5 and 6, rabbit &#x003b1;-defensin NP-1 and NP-2 [<xref ref-type="bibr" rid="CR19">19</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>]. In terms of &#x003b2;-defensins, human &#x003b2;-defensin (HBD) 3 and a synthetic &#x003b2;-defensin analog constituted by domains of HBD-1 and HBD-3 have been confirmed to inactivate HSV [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Bovine neutrophil &#x003b2;-defensin 3 has been found to show inhibitory activity against bovine herpes virus 1 [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. Besides, HBD-2 has been reported to inhibit varicella zoster virus infection [<xref ref-type="bibr" rid="CR29">29</xref>]. Retrocyclins 1 and 2 and rhesus &#x003b8; defensin 3 belonging to &#x003b8;-defensins have been found to suppress HSV infection [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Therefore, the utilization of defensins as drugs or target genes for generation of disease-resistant animals may be useful to control virus infection.</p><p id="Par22">Although swine serves as the natural host and reservoir of PRV, mice are often utilized as a preferred model organism to study PRV infection because of their susceptibility to PRV. In this study, the effects of PBD-2 on the proliferation of PRV were investigated both in PK-15 cells and transgenic (TG) mice generated in our previous study [<xref ref-type="bibr" rid="CR13">13</xref>]. The results confirmed the effectiveness of PBD-2 to suppress virus proliferation and provided novel ideas to control PRV infection.</p></sec><sec id="Sec2"><title>Materials and methods</title><sec id="Sec3"><title>Cell line and virus</title><p id="Par23">The PRV strain Ea, isolated from Hubei province of China, was used in this study [<xref ref-type="bibr" rid="CR32">32</xref>]. Porcine PK-15 cells were maintained in Dulbecco&#x02019;s Modified Eagle Medium (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with 10% fetal bovine serum (FBS) (Thermo Fisher Scientific) in an atmosphere of 5% CO<sub>2</sub> at 37&#x02009;&#x000b0;C.</p></sec><sec id="Sec4"><title>Propagation and titration of PRV</title><p id="Par24">PK-15 cells were used to propagate PRV. Briefly, 100&#x02009;&#x003bc;L of virus stock was added to PK-15 cells which reached 70% confluence on a T75 cell culture flask for 1&#x02009;h at 37&#x02009;&#x000b0;C. After removal of virus inoculum, 15&#x02009;mL of maintenance medium was added. When 80% cytopathic effect (CPE) was present, cells were harvested and repeatedly freeze-thawed before centrifugation. PRV was obtained in the supernatant and titration of PRV was measured and calculated using the Reed-Muench method in accordance with protocols described previously [<xref ref-type="bibr" rid="CR33">33</xref>].</p></sec><sec id="Sec5"><title>Cytotoxicity assay</title><p id="Par25">Cell Counting Kit-8 (CCK-8) (DOJINDO, Shanghai, China) assay was used to determine cell viability in accordance with the manufactures&#x02019; instruction. Briefly, 100&#x02009;&#x003bc;L of PK-15 cell suspension (6000 cells/well) was inoculated in a 96-well plate. After 4&#x02009;h in culture, cells were attached to the bottom of the plate. Different concentrations of PBD-2 ranging from 5 to 80&#x02009;&#x003bc;g/mL were subsequently added into the plate without the presence of FBS. Cells were co-incubated with PBD-2 at 37&#x02009;&#x000b0;C for 16&#x02009;h before adding 10&#x02009;&#x003bc;L of the CCK-8 solution. After another three-hour incubation, the absorbance was measured at 450&#x02009;nm using a microplate reader (TECAN, Z&#x000fc;rich, Switzerland). Cell viability (% of control)&#x02009;=&#x02009;[(absorbance of test sample - absorbance of blank)/(absorbance of control - absorbance of blank)]&#x02009;&#x000d7;&#x02009;100%.</p></sec><sec id="Sec6"><title>Detection of antiviral effect of PBD2 in PK-15</title><p id="Par26">Synthetic mature PBD-2 peptide (DHYICAKKGGTCNFSPCPLFNRIEGTCYSGKAKCCIR, ChinaPeptides, Shanghai, China) was used to evaluate its antiviral activity against PRV. PRV stocks diluted in DPBS were preincubated with PBD-2 of different concentrations (5&#x02009;&#x003bc;g/mL, 10&#x02009;&#x003bc;g/mL, 20&#x02009;&#x003bc;g/mL, 40&#x02009;&#x003bc;g/mL, 80&#x02009;&#x003bc;g/mL) at 37&#x02009;&#x000b0;C for 1&#x02009;h. The mixture was then added to a 96-well plate with 10,000 cells in each well (MOI&#x02009;=&#x02009;0.1), and the plate was incubated at 37&#x02009;&#x000b0;C for another 1&#x02009;h. The inoculums were discarded and wells were washed with PBS before adding fresh maintenance medium. After 48&#x02009;h, cell culture supernatants were collected for viral DNA isolation using a Quick-DNA/RNA Viral Kit (Zymo Research, Irvine, CA, USA). The resulting viral DNA was subjected to real-time quantitative PCR (RT-qPCR) along with a standard plasmid. The plasmid containing a glycoprotein D (gD) gene, a highly conservative gene of PRV, was serially diluted and subjected to RT-qPCR to generate a standard curve using the primers P1 (5&#x02032;-CATCCTCACCGACTTCAT-3&#x02032;) and P2 (5&#x02032;-TACCAGTAGTTCACCACC-3&#x02032;) for amplifying a part of gD gene which is 192&#x02009;bp in length. The number of PRV copies was determined from the standard curve by converting the corresponding Ct value.</p></sec><sec id="Sec7"><title>Mice grouping and viability test of PRV infection</title><p id="Par27">C57/BL TG mice expressing PBD-2 were generated by our lab previously [<xref ref-type="bibr" rid="CR13">13</xref>]. Genomic DNA from mouse tail samples was extracted and used for identification of TG mice expressing PBD-2 by using primers NP03 (5&#x02032;-GCTGGTTGTTGTGCTGTCTC-3&#x02032;) and NP04 (5&#x02032;-AGGTCCCTTCAATCCTGTTG-3&#x02032;). At 6&#x02013;8&#x02009;weeks of age, TG mice (<italic>n</italic>&#x02009;=&#x02009;4) weighing 20&#x02009;&#x000b1;&#x02009;2&#x02009;g were intraperitoneally injected with 0.2&#x02009;mL of PRV (2&#x000a0;&#x000d7;&#x000a0;10<sup>3.3</sup> TCID<sub>50</sub>/mL) each. Their wild-type (WT) littermates (<italic>n</italic>&#x02009;=&#x02009;4) were treated with the same amount of PRV each. Survival was assessed in two groups of mice daily for 10&#x02009;days.</p></sec><sec id="Sec8"><title>Quantification of PRV copies in mice tissues</title><p id="Par28">Both TG and WT mice intraperitoneally injected with 0.2&#x02009;mL of PRV (2&#x02009;&#x000d7;&#x02009;10<sup>3.3</sup> TCID<sub>50</sub>/mL) were sacrificed on day 5 post-infection and brain, spleen, liver and lung were harvested for further analyses. DNA from 30&#x02009;mg of brain, liver and lung tissues each was extracted using E.Z.N.A Tissue DNA kit (Omega Bio-tek, Norcross, GA, USA) according to the manufacturer&#x02019;s instructions. The PRV copies in the total DNA of tissue samples were measured by RT-qPCR and calculated as described above.</p></sec><sec id="Sec9"><title>Histopathological analysis</title><p id="Par29">Brain, spleen and liver tissues from TG and WT mice were fixed in PBS-buffered 4% formaldehyde for 48&#x02009;h at 37&#x02009;&#x000b0;C. Tissues were than embedded in paraffin and sliced into sections of 5&#x02009;&#x003bc;m thickness. After that, sections were subjected to haematoxylin and eosin (HE) staining. Tissue lesions were observed under a microscope.</p></sec><sec id="Sec10"><title>Statistics</title><p id="Par30">Statistical analyses were performed with GraphPad Prism 5 (GraphPad Software, La Jolla, CA, USA) using unpaired one-tailed Student&#x02019;s <italic>t</italic>-test and shown as mean&#x02009;&#x000b1;&#x02009;SD. *<italic>P</italic>&#x02009;&#x0003c;&#x02009;.05, **<italic>P</italic>&#x02009;&#x0003c;&#x02009;.01, ***<italic>P</italic>&#x02009;&#x0003c;&#x02009;.001, ****<italic>P</italic>&#x02009;&#x0003c;&#x02009;.0001.</p></sec></sec><sec id="Sec11"><title>Results</title><sec id="Sec12"><title>Antiviral effect of PBD-2 in PK-15 cells</title><p id="Par31">The cytotoxicity of PBD-2 on PK-15 was evaluated using CCK-8 assay. The cell viability analysis indicated that PBD-2 displayed no significant cytotoxicity on PK-15 cells at a maximum concentration of 80&#x02009;&#x003bc;g/mL and at a minimum concentration of 5&#x02009;&#x003bc;g/mL (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>a). Then, PBD-2 of different concentrations were used to assess the antiviral effect against PRV in PK-15 cells. Compared with PRV without pretreatment of PBD-2, significant reduction in viral titer was observed when PRV was pre-incubated with 40&#x02009;&#x003bc;g/mL and 80&#x02009;&#x003bc;g/mL of PBD-2 (<italic>P</italic>&#x000a0;&#x0003c;&#x000a0;.05) (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). These results indicated that PBD-2 at a relatively high concentration could significantly inhibit PRV proliferation in PK-15 cells without cytotoxicity activity.
<fig id="Fig1"><label>Fig. 1</label><caption><p>Effect of porcine &#x003b2;-defensin 2 (PBD-2) on PK-15 cells. <bold>a</bold> Cytotoxicity of PBD-2 on PK-15 cells. PK-15 cells were incubated with different concentrations of PBD-2 for 16&#x02009;h (5, 10, 20, 40, 80&#x02009;&#x003bc;g/mL). The cytotoxicity was measured by CCK-8 assay (<italic>n</italic>&#x02009;=&#x02009;8); <bold>b</bold> Pseudorabies virus (PRV) was pre-incubated with PBD-2 of different concentrations and used to inoculate cells, the PRV copies were measured 2&#x02009;days after infection (<italic>n</italic>&#x02009;=&#x02009;5). Data are presented as mean&#x02009;&#x000b1;&#x02009;SD from three independent experiments. * <italic>P</italic>&#x0003c;0.05, **<italic>P</italic>&#x0003c;0.01, ns&#x02009;=&#x02009;no significance, unpaired one tailed Student&#x02032;s&#x02009;<italic>t</italic>-test</p></caption><graphic xlink:href="12985_2020_1288_Fig1_HTML" id="MO1"/></fig></p></sec><sec id="Sec13"><title>Survival rate analysis of TG mice after infection of PRV</title><p id="Par32">The antiviral effect of PBD-2 on the survival of mice infected with PRV was investigated. WT mice intraperitoneally infected with 0.2&#x02009;mL of PRV (2&#x02009;&#x000d7;&#x02009;10<sup>3.3</sup> TCID<sub>50</sub>/mL) showed a survival rate of 25% while expression of PBD-2 increased the survival rate of TG mice to 75% (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). Thus, the results revealed that TG mice expression PBD-2 were more resistant to PRV infection than control mice.
<fig id="Fig2"><label>Fig. 2</label><caption><p>Survival of transgenic mice (TG) expressing PBD-2 and wild-type (WT) mice after PRV infection (<italic>n</italic>&#x02009;=&#x02009;4 for each group). The mice were intraperitoneally injected of 0.2&#x02009;mL of PRV (2&#x02009;&#x000d7;&#x02009;10<sup>3.3</sup> TCID<sub>50</sub>/mL). This result represents three independent experiments with similar results</p></caption><graphic xlink:href="12985_2020_1288_Fig2_HTML" id="MO2"/></fig></p></sec><sec id="Sec14"><title>Viral loads in TG mice after PRV infection</title><p id="Par33">The PRV genomic copy numbers were quantified in brain, liver and lung tissues of TG and WT mice infected with PRV by RT-qPCR. PRV viral loads in brain tissues of TG mice and WT mice were higher than those in liver and lung tissues. However, PRV viral loads in brain (<italic>P</italic>&#x02009;&#x0003c;&#x02009;.001), liver (<italic>P</italic>&#x02009;&#x0003c;&#x02009;.0001) and lung (<italic>P</italic>&#x02009;&#x0003c;&#x02009;.05) of TG mice were significantly lower than that of WT mice (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). Hence, PBD-2 could significantly depress viral loads of PRV in different tissues.
<fig id="Fig3"><label>Fig. 3</label><caption><p>Viral loads of PRV in tissue samples of mice infected with PRV. Total DNA used to determine PRV copy numbers were obtained from brain, liver and lung tissues of WT and TG mice (<italic>n</italic>&#x02009;=&#x02009;4 for each group) on day 5 after PRV injection. Data are presented as mean&#x02009;&#x000b1;&#x02009;SD and are plotted from three independent experiments. *<italic>P</italic>&#x0003c;0.05, ***<italic>P</italic>&#x0003c;0.001, ****<italic>P</italic>&#x0003c;0.0001, unpaired one tailed Student&#x02032; s <italic>t</italic>-test with Welch&#x02032; s correction</p></caption><graphic xlink:href="12985_2020_1288_Fig3_HTML" id="MO3"/></fig></p></sec><sec id="Sec15"><title>Histopathological analysis of TG mice after infection of PRV</title><p id="Par34">The pathological changes of WT mice and TG mice after PRV infection were also detected. Microglia nodules associated with neuronal degeneration and necrosis were observed in brain tissue of WT mice (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>a) while neuron swelling, dissolution of Nissl bodies and basophilic inclusions were present in TG mice (Fig. <xref rid="Fig4" ref-type="fig">4</xref>b). Besides, necrosis of cells was found in spleen tissue of WT mice (Fig. <xref rid="Fig4" ref-type="fig">4</xref>c) and TG mice showed a slight hyperemia in spleen (Fig. <xref rid="Fig4" ref-type="fig">4</xref>d). Degeneration of cells and congestion in the liver of WT mice were observed (Fig. <xref rid="Fig4" ref-type="fig">4</xref>e) while there were no apparent lesions in that of TG mice (Fig. <xref rid="Fig4" ref-type="fig">4</xref>f). Together, these results demonstrated that TG mice displayed milder tissue lesions than WT mice after PRV infection.
<fig id="Fig4"><label>Fig. 4</label><caption><p>Histopathological analysis on brain, spleen and liver tissues of TG and WT mice infected with PRV. Tissues were fixed in 4% formaldehyde and subsequently embedded paraffin for sectioning and HE staining. Black arrows indicate histopathological damages. <bold>a</bold>, <bold>c</bold> and <bold>e</bold> showed HE stained brain, spleen and liver tissues of represented WT mice; <bold>b</bold>, <bold>d</bold>, <bold>f</bold> showed HE stained brain, spleen and liver tissues of represented TG mice</p></caption><graphic xlink:href="12985_2020_1288_Fig4_HTML" id="MO4"/></fig></p></sec></sec><sec id="Sec16"><title>Discussion</title><p id="Par35">The impact of PBD-2 on viral pathogenicity has not been well examined experimentally yet. A previous study has showed that PBD-2 exhibits antiviral ability against PRRSV when the concentration reaches 64&#x02009;&#x003bc;g/mL [<xref ref-type="bibr" rid="CR8">8</xref>]. Similarly, in this study, PBD-2 at 40&#x02009;&#x003bc;g/mL and 80&#x02009;&#x003bc;g/mL was found to inhibit PRV proliferation in PK-15 cells while no significant effect was observed for lower concentrations of PBD-2 (Fig. <xref rid="Fig1" ref-type="fig">1</xref>b). These indicate that a threshold concentration is required for PBD-2 to inhibit viral proliferation. According to the survivability, detectable virus copies and pathological changes, the TG mice displayed significantly increased resistance to PRV infection compared with the WT mice. Therefore, the antiviral effect of PBD-2 was confirmed both on cells and in TG mice expressing PBD-2. It has been revealed that defensins can direct inactive enveloped viruses by disrupting viral lipid bilayers [<xref ref-type="bibr" rid="CR34">34</xref>]. In this study, PRV was preincubated with PBD-2 and then used to infect cells. According to the result, we hypothesize that PBD-2 might have a direct virucidal effect on PRV by damaging the viral envelopes. Besides, it may also affect PRV entry because PBD-2 was still present during the whole process of viral adsorption. Since PRV shared high structural and sequence similarity with other alphaherpesviruses [<xref ref-type="bibr" rid="CR15">15</xref>], the antiviral mechanisms of other defensins against alphaherpesviruses would help understand how PBD-2 inhibited PRV proliferation. HNP-4 and HD-6 were capable of block HSV binding by interacting with heparan sulfate, the primary receptor for HSV binding, while HBD-3 with enhanced inhibitory effect against HSV bound both heparan sulfate and gB [<xref ref-type="bibr" rid="CR20">20</xref>]. HD-5 was able to prevent viral adhesion and entry of HSV by binding to both gB and gD [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Likewise, rabbit NP-1 and HNP-1, -2, -3 inactivated HSV by preventing viral entry [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]. Retrocyclin 2 prevented HSV binding, entry and intercellular spread by binding carbohydrate moieties on glycoprotein B [<xref ref-type="bibr" rid="CR31">31</xref>]. In general, these defensins prevent HSV infection by blocking viral binding, penetration or both. Whether PBD-2 is able to block viral binding and penetration by interacting with specific host membrane receptor(s) can be further studied.</p><p id="Par36">Defensins have been confirmed to be effective to resist pathogens. Chen et al. argued that higher expression levels of PBD-2 and other &#x003b2;-defensins in Meishan pigs than those in crossbred pigs conferred stronger immunity of Meishan pigs against diseases [<xref ref-type="bibr" rid="CR36">36</xref>]. Our previous study revealed that PBD-2 overexpressing pigs and PBD-2 TG mice showed enhanced resistance to bacterial infection [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. In this study, we further verified that PBD-2 TG mice displayed increased resistance to viral infection. Thus, PBD-2 can be a useful target to generate disease-resistant animals against both bacterial and viral infections. PRV is an important pig pathogen which is still present in China, Japan, USA and some European countries [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. The inhibitory effect of PBD-2 in vitro and in vivo discovered in this study provided possible new strategies to control PRV, such as overexpressing PBD-2 in pig tissues. In transgenic mice infected with PRV, PBD-2 could reduce viral loads and alleviated tissue lesions at different degrees in different tissues (Figs.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref> and <xref rid="Fig4" ref-type="fig">4</xref>). Our previous study has discovered that PBD-2 expression level in organs differed in TG mice [<xref ref-type="bibr" rid="CR39">39</xref>], which suggests a correlation between PBD-2 expression level and its anti-PRV effect in different organs. It is worth noting that PRV loads of brain tissues (Fig. <xref rid="Fig3" ref-type="fig">3</xref>) were the highest and damages of brain tissues were the severest (Fig. <xref rid="Fig4" ref-type="fig">4</xref>) either in TG mice or in WT mice, confirming that PRV had a distinct tissue tropism [<xref ref-type="bibr" rid="CR15">15</xref>]. Herein, increasing PBD-2 expression in animals, especially in brains, using gene-editing techniques might promote the resistance of animals to PRV in vivo.</p><p id="Par37">On the other hand, PBD-2 may be used as drug additives or vaccine adjuvants to develop alternative strategies to control PRV and other viruses. Attempts at using &#x003b2;-defensins to control viral diseases in vivo have been carried out. Expression of zebrafish &#x003b2;-defensin 2 in fishes improved their resistance to spring viraemia of carp virus infection [<xref ref-type="bibr" rid="CR40">40</xref>]. Application of murine &#x003b2;-defensin 2 as a DNA vaccine adjuvant protected mice against H5N1 avian influenza viruses [<xref ref-type="bibr" rid="CR41">41</xref>]. In addition, mice intranasally or intratracheally inoculated with P9, a derivative of mouse &#x003b2;-defensin 4, were protected from infections of three types of influenza A viruses and SARS-associated coronavirus [<xref ref-type="bibr" rid="CR42">42</xref>]. Besides, intraperitoneal injection of recombinant mouse &#x003b2;-defensin 3 (rMBD3) in mice was found to alleviate coxsackievirus B3-induced myocarditis [<xref ref-type="bibr" rid="CR43">43</xref>]. Similarly, intravenous injection of rMBD3 improved the survival rate of mice infected with influenza A virus [<xref ref-type="bibr" rid="CR44">44</xref>].</p></sec><sec id="Sec17"><title>Conclusions</title><p id="Par38">In summary, within this study, the antiviral effect of PBD-2 in vitro and in vivo were confirmed using PRV infection model. The technique of large-scale production of PBD-2 [<xref ref-type="bibr" rid="CR45">45</xref>] and the existing transgenic pigs overexpressing PBD-2 [<xref ref-type="bibr" rid="CR10">10</xref>] have created possibilities for the application of PBD-2 as novel prophylactic and therapeutic methods against Aujeszky&#x02019;s disease and other viral diseases. In addition, it is worthy of further studies on the underlying mechanism for the inhibitory effect of PBD-2 on PRV, which will offer more insights regarding antiviral effects of defensins.</p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>CCK-8</term><def><p id="Par5">Cell counting kit-8</p></def></def-item><def-item><term>CPE</term><def><p id="Par6">Cytopathic effect</p></def></def-item><def-item><term>FBS</term><def><p id="Par7">Fetal bovine serum</p></def></def-item><def-item><term>gD</term><def><p id="Par8">Glycoprotein D</p></def></def-item><def-item><term>HBD</term><def><p id="Par9">Human &#x003b2;-defensin</p></def></def-item><def-item><term>HD</term><def><p id="Par10">Human &#x003b1;-defensin</p></def></def-item><def-item><term>HE</term><def><p id="Par11">Haematoxylin and eosin</p></def></def-item><def-item><term>HNP</term><def><p id="Par12">Human neutrophil peptide</p></def></def-item><def-item><term>HSV</term><def><p id="Par13">Herpes simplex virus</p></def></def-item><def-item><term>PBD-2</term><def><p id="Par14">Porcine &#x003b2;-defensin 2</p></def></def-item><def-item><term>PRV</term><def><p id="Par15">Pseudorabies virus</p></def></def-item><def-item><term>rMBD-3</term><def><p id="Par16">Recombinant murine &#x003b2;-defensin 3</p></def></def-item><def-item><term>TG</term><def><p id="Par17">Transgenic</p></def></def-item><def-item><term>WT</term><def><p id="Par18">Wild-type</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher&#x02019;s Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Jing Huang and Yanhua Qi contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Professor Qigai He from Huazhong Agricultural University for providing the pseudorabies virus Ea strain used in this study.</p></ack><notes notes-type="author-contribution"><title>Authors&#x02019; contributions</title><p>JH, RZ and LL designed the experiments; JH, YQ performed the experiments; AW and CH analyzed the data; XL and XY provided the materials; JH and LL wrote the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study was founded by the National Transgenic Project of China (Grant No. 2016ZX08006003&#x02013;004), National Key R &#x00026; D Program of China (Grant No. 2017YFD0500201), and Hubei Province Natural Science Foundation for Innovative Research Groups (Grant No. 2016CFA015).</p></notes><notes notes-type="data-availability"><title>Availability of data and materials</title><p>Detailed data will be available on request.</p></notes><notes><title>Ethics approval and consent to participate</title><p id="Par39">All animal experimental procedures were performed in accordance with the Hubei Regulations for the Administration of Affairs Concerning Experimental Animals. Animal experiments in this study were subject to approval by the Hubei Province Science and Technology Department, concerning experimental animal ethics. The experiments were carried out under the supervision and inspection of the Scientific Ethical Committee for Experimental Animals of Huazhong Agricultural University, Wuhan, China.</p></notes><notes><title>Consent for publication</title><p id="Par40">Informed consent was obtained from all contributing authors included in this study.</p></notes><notes notes-type="COI-statement"><title>Competing interests</title><p id="Par41">The authors declare that they have no competing interest.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Holly</surname><given-names>MK</given-names></name><name><surname>Diaz</surname><given-names>K</given-names></name><name><surname>Smith</surname><given-names>JG</given-names></name></person-group><article-title>Defensins in viral infection and pathogenesis</article-title><source>Annu Rev Virol</source><year>2017</year><volume>4</volume><fpage>369</fpage><lpage>391</lpage><pub-id pub-id-type="doi">10.1146/annurev-virology-101416-041734</pub-id><?supplied-pmid 28715972?><pub-id pub-id-type="pmid">28715972</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehrer</surname><given-names>RI</given-names></name></person-group><article-title>Primate defensins</article-title><source>Nat Rev Microbiol</source><year>2004</year><volume>2</volume><fpage>727</fpage><lpage>738</lpage><pub-id pub-id-type="doi">10.1038/nrmicro976</pub-id><?supplied-pmid 15372083?><pub-id pub-id-type="pmid">15372083</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Selsted</surname><given-names>ME</given-names></name><name><surname>Ouellette</surname><given-names>AJ</given-names></name></person-group><article-title>Mammalian defensins in the antimicrobial immune response</article-title><source>Nat Immunol</source><year>2005</year><volume>6</volume><fpage>551</fpage><lpage>557</lpage><pub-id pub-id-type="doi">10.1038/ni1206</pub-id><?supplied-pmid 15908936?><pub-id pub-id-type="pmid">15908936</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>MK</given-names></name><name><surname>Le</surname><given-names>MT</given-names></name><name><surname>Nguyen</surname><given-names>DT</given-names></name><name><surname>Choi</surname><given-names>H</given-names></name><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Kim</surname><given-names>JH</given-names></name><name><surname>Chun</surname><given-names>J</given-names></name><name><surname>Hyeon</surname><given-names>J</given-names></name><name><surname>Seo</surname><given-names>K</given-names></name><name><surname>Park</surname><given-names>C</given-names></name></person-group><article-title>Genome-level identification, gene expression, and comparative analysis of porcine ss-defensin genes</article-title><source>BMC Genet</source><year>2012</year><volume>13</volume><fpage>98</fpage><pub-id pub-id-type="doi">10.1186/1471-2156-13-98</pub-id><?supplied-pmid 23150902?><pub-id pub-id-type="pmid">23150902</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sang</surname><given-names>Y</given-names></name><name><surname>Blecha</surname><given-names>F</given-names></name></person-group><article-title>Porcine host defense peptides: expanding repertoire and functions</article-title><source>Dev Comp Immunol</source><year>2009</year><volume>33</volume><fpage>334</fpage><lpage>343</lpage><pub-id pub-id-type="doi">10.1016/j.dci.2008.05.006</pub-id><?supplied-pmid 18579204?><pub-id pub-id-type="pmid">18579204</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sang</surname><given-names>Y</given-names></name><name><surname>Patil</surname><given-names>AA</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Ross</surname><given-names>CR</given-names></name><name><surname>Blecha</surname><given-names>F</given-names></name></person-group><article-title>Bioinformatic and expression analysis of novel porcine beta-defensins</article-title><source>Mamm Genome</source><year>2006</year><volume>17</volume><fpage>332</fpage><lpage>339</lpage><pub-id pub-id-type="doi">10.1007/s00335-005-0158-0</pub-id><?supplied-pmid 16596454?><pub-id pub-id-type="pmid">16596454</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>YY</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>CY</given-names></name><name><surname>Xiao</surname><given-names>CB</given-names></name><name><surname>Li</surname><given-names>CL</given-names></name></person-group><article-title>Preparation of polyclonal antibody against porcine beta defensin 2 and identification of its distribution in tissues of pig</article-title><source>Genet Mol Res</source><year>2015</year><volume>14</volume><fpage>18863</fpage><lpage>18871</lpage><pub-id pub-id-type="doi">10.4238/2015.December.28.36</pub-id><?supplied-pmid 26782537?><pub-id pub-id-type="pmid">26782537</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veldhuizen</surname><given-names>EJ</given-names></name><name><surname>Rijnders</surname><given-names>M</given-names></name><name><surname>Claassen</surname><given-names>EA</given-names></name><name><surname>van Dijk</surname><given-names>A</given-names></name><name><surname>Haagsman</surname><given-names>HP</given-names></name></person-group><article-title>Porcine beta-defensin 2 displays broad antimicrobial activity against pathogenic intestinal bacteria</article-title><source>Mol Immunol</source><year>2008</year><volume>45</volume><fpage>386</fpage><lpage>394</lpage><pub-id pub-id-type="doi">10.1016/j.molimm.2007.06.001</pub-id><?supplied-pmid 17658606?><pub-id pub-id-type="pmid">17658606</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Zhong</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Huo</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Cui</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Construction of Bacillus subtilis strain engineered for expression of porcine beta-defensin-2/cecropin P1 fusion antimicrobial peptides and its growth-promoting effect and antimicrobial activity</article-title><source>Asian-Australas J Anim Sci</source><year>2017</year><volume>30</volume><fpage>576</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.5713/ajas.16.0207</pub-id><?supplied-pmid 27383796?><pub-id pub-id-type="pmid">27383796</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Cheng</surname><given-names>YT</given-names></name><name><surname>Tan</surname><given-names>MF</given-names></name><name><surname>Zhang</surname><given-names>HW</given-names></name><name><surname>Liu</surname><given-names>WQ</given-names></name><name><surname>Zou</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>LS</given-names></name><name><surname>Zhang</surname><given-names>CY</given-names></name><name><surname>Deng</surname><given-names>SM</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><etal/></person-group><article-title>Overexpression of porcine Beta-Defensin 2 enhances resistance to Actinobacillus pleuropneumoniae infection in pigs</article-title><source>Infect Immun</source><year>2015</year><volume>83</volume><fpage>2836</fpage><lpage>2843</lpage><pub-id pub-id-type="doi">10.1128/IAI.03101-14</pub-id><?supplied-pmid 25916992?><pub-id pub-id-type="pmid">25916992</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Xia</surname><given-names>X</given-names></name><name><surname>Xiong</surname><given-names>H</given-names></name><name><surname>Song</surname><given-names>D</given-names></name><name><surname>Zong</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Porcine beta-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis</article-title><source>J Immunol</source><year>2015</year><volume>194</volume><fpage>1882</fpage><lpage>1893</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.1402300</pub-id><?supplied-pmid 25601921?><pub-id pub-id-type="pmid">25601921</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>L</given-names></name><name><surname>Shi</surname><given-names>B</given-names></name><name><surname>Deng</surname><given-names>H</given-names></name><name><surname>Lai</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>Z</given-names></name></person-group><article-title>Oral administration of synthetic porcine beta-defensin-2 improves growth performance and cecal microbial flora and down-regulates the expression of intestinal toll-like receptor-4 and inflammatory cytokines in weaned piglets challenged with enterotoxigenic Escherichia coli</article-title><source>Anim Sci J</source><year>2016</year><volume>87</volume><fpage>1258</fpage><lpage>1266</lpage><pub-id pub-id-type="doi">10.1111/asj.12540</pub-id><?supplied-pmid 26707031?><pub-id pub-id-type="pmid">26707031</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name></person-group><article-title>Porcine Beta-Defensin 2 provides protection against bacterial infection by a direct bactericidal activity and alleviates inflammation via interference with the TLR4/NF-kappaB pathway</article-title><source>Front Immunol</source><year>2019</year><volume>10</volume><fpage>1673</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2019.01673</pub-id><?supplied-pmid 31379864?><pub-id pub-id-type="pmid">31379864</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintero-Gil</surname><given-names>C</given-names></name><name><surname>Parra-Suescun</surname><given-names>J</given-names></name><name><surname>Lopez-Herrera</surname><given-names>A</given-names></name><name><surname>Orduz</surname><given-names>S</given-names></name></person-group><article-title>In-silico design and molecular docking evaluation of peptides derivatives from bacteriocins and porcine beta defensin-2 as inhibitors of hepatitis E virus capsid protein</article-title><source>Virusdisease</source><year>2017</year><volume>28</volume><fpage>281</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1007/s13337-017-0383-7</pub-id><?supplied-pmid 29291214?><pub-id pub-id-type="pmid">29291214</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Mettenleiter</surname><given-names>TC</given-names></name></person-group><person-group person-group-type="editor"><name><surname>BWJ</surname><given-names>M</given-names></name><name><surname>MHV</surname><given-names>VR</given-names></name></person-group><source>Pseudorabies Virus. In Encyclopedia of Virology (Third Edition)</source><year>2008</year><publisher-loc>Oxford</publisher-loc><publisher-name>Academic Press</publisher-name><fpage>341</fpage><lpage>351</lpage></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>CH</given-names></name><name><surname>Yuan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>N</given-names></name><name><surname>Song</surname><given-names>K</given-names></name><name><surname>Qiu</surname><given-names>HJ</given-names></name></person-group><article-title>Control of swine pseudorabies in China: opportunities and limitations</article-title><source>Vet Microbiol</source><year>2016</year><volume>183</volume><fpage>119</fpage><lpage>124</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2015.12.008</pub-id><?supplied-pmid 26790944?><pub-id pub-id-type="pmid">26790944</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tong-Qing</surname><given-names>A</given-names></name><name><surname>Jin-Mei</surname><given-names>P</given-names></name><name><surname>Zhi-Jun</surname><given-names>T</given-names></name><name><surname>Hong-Yuan</surname><given-names>Z</given-names></name><name><surname>Na</surname><given-names>L</given-names></name><name><surname>Yi-Min</surname><given-names>L</given-names></name><name><surname>Jia-Zeng</surname><given-names>C</given-names></name><name><surname>Chao-Liang</surname><given-names>L</given-names></name><name><surname>Yan</surname><given-names>S</given-names></name><name><surname>Dan</surname><given-names>C</given-names></name><name><surname>Guang-Zhi</surname><given-names>T</given-names></name></person-group><article-title>Pseudorabies virus variant in Bartha-K61&#x02013;vaccinated pigs, China, 2012</article-title><source>Emerg Infect Dis J</source><year>2013</year><volume>19</volume><fpage>1749</fpage><pub-id pub-id-type="doi">10.3201/eid1911.130177</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>S</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Zhai</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Ni</surname><given-names>J</given-names></name><name><surname>Yuan</surname><given-names>L</given-names></name><name><surname>Song</surname><given-names>X</given-names></name><etal/></person-group><article-title>Investigation on pseudorabies prevalence in Chinese swine breeding farms in 2013-2016</article-title><source>Trop Anim Health Prod</source><year>2018</year><volume>50</volume><fpage>1279</fpage><lpage>1285</lpage><pub-id pub-id-type="doi">10.1007/s11250-018-1555-1</pub-id><?supplied-pmid 29556961?><pub-id pub-id-type="pmid">29556961</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Daher</surname><given-names>KA</given-names></name><name><surname>Selsted</surname><given-names>ME</given-names></name><name><surname>Lehrer</surname><given-names>RI</given-names></name></person-group><article-title>Direct inactivation of viruses by human granulocyte defensins</article-title><source>J Virol</source><year>1986</year><volume>60</volume><fpage>1068</fpage><lpage>1074</lpage><pub-id pub-id-type="doi">10.1128/JVI.60.3.1068-1074.1986</pub-id><?supplied-pmid 3023659?><pub-id pub-id-type="pmid">3023659</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hazrati</surname><given-names>E</given-names></name><name><surname>Galen</surname><given-names>B</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Ouyang</surname><given-names>Y</given-names></name><name><surname>Keller</surname><given-names>MJ</given-names></name><name><surname>Lehrer</surname><given-names>RI</given-names></name><name><surname>Herold</surname><given-names>BC</given-names></name></person-group><article-title>Human alpha- and beta-defensins block multiple steps in herpes simplex virus infection</article-title><source>J Immunol</source><year>2006</year><volume>177</volume><fpage>8658</fpage><lpage>8666</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.177.12.8658</pub-id><?supplied-pmid 17142766?><pub-id pub-id-type="pmid">17142766</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehrer</surname><given-names>RI</given-names></name><name><surname>Jung</surname><given-names>G</given-names></name><name><surname>Ruchala</surname><given-names>P</given-names></name><name><surname>Andre</surname><given-names>S</given-names></name><name><surname>Gabius</surname><given-names>HJ</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name></person-group><article-title>Multivalent binding of carbohydrates by the human alpha-defensin, HD5</article-title><source>J Immunol</source><year>2009</year><volume>183</volume><fpage>480</fpage><lpage>490</lpage><pub-id pub-id-type="doi">10.4049/jimmunol.0900244</pub-id><?supplied-pmid 19542459?><pub-id pub-id-type="pmid">19542459</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sinha</surname><given-names>S</given-names></name><name><surname>Cheshenko</surname><given-names>N</given-names></name><name><surname>Lehrer</surname><given-names>RI</given-names></name><name><surname>Herold</surname><given-names>BC</given-names></name></person-group><article-title>NP-1, a rabbit alpha-defensin, prevents the entry and intercellular spread of herpes simplex virus type 2</article-title><source>Antimicrob Agents Chemother</source><year>2003</year><volume>47</volume><fpage>494</fpage><lpage>500</lpage><pub-id pub-id-type="doi">10.1128/AAC.47.2.494-500.2003</pub-id><?supplied-pmid 12543649?><pub-id pub-id-type="pmid">12543649</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Geng</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Ran</surname><given-names>X</given-names></name><etal/></person-group><article-title>Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites</article-title><source>J Virol</source><year>2013</year><volume>87</volume><fpage>2835</fpage><lpage>2845</lpage><pub-id pub-id-type="doi">10.1128/JVI.02209-12</pub-id><?supplied-pmid 23269800?><pub-id pub-id-type="pmid">23269800</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasin</surname><given-names>B</given-names></name><name><surname>Pang</surname><given-names>M</given-names></name><name><surname>Turner</surname><given-names>JS</given-names></name><name><surname>Cho</surname><given-names>Y</given-names></name><name><surname>Dinh</surname><given-names>NN</given-names></name><name><surname>Waring</surname><given-names>AJ</given-names></name><name><surname>Lehrer</surname><given-names>RI</given-names></name><name><surname>Wagar</surname><given-names>EA</given-names></name></person-group><article-title>Evaluation of the inactivation of infectious herpes simplex virus by host-defense peptides</article-title><source>Eur J Clin Microbiol Infect Dis</source><year>2000</year><volume>19</volume><fpage>187</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1007/s100960050457</pub-id><?supplied-pmid 10795591?><pub-id pub-id-type="pmid">10795591</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nigro</surname><given-names>E</given-names></name><name><surname>Colavita</surname><given-names>I</given-names></name><name><surname>Sarnataro</surname><given-names>D</given-names></name><name><surname>Scudiero</surname><given-names>O</given-names></name><name><surname>Zambrano</surname><given-names>G</given-names></name><name><surname>Granata</surname><given-names>V</given-names></name><name><surname>Daniele</surname><given-names>A</given-names></name><name><surname>Carotenuto</surname><given-names>A</given-names></name><name><surname>Galdiero</surname><given-names>S</given-names></name><name><surname>Folliero</surname><given-names>V</given-names></name><etal/></person-group><article-title>An ancestral host defence peptide within human beta-defensin 3 recapitulates the antibacterial and antiviral activity of the full-length molecule</article-title><source>Sci Rep</source><year>2015</year><volume>5</volume><fpage>18450</fpage><pub-id pub-id-type="doi">10.1038/srep18450</pub-id><?supplied-pmid 26688341?><pub-id pub-id-type="pmid">26688341</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scudiero</surname><given-names>O</given-names></name><name><surname>Nigro</surname><given-names>E</given-names></name><name><surname>Cantisani</surname><given-names>M</given-names></name><name><surname>Colavita</surname><given-names>I</given-names></name><name><surname>Leone</surname><given-names>M</given-names></name><name><surname>Mercurio</surname><given-names>FA</given-names></name><name><surname>Galdiero</surname><given-names>M</given-names></name><name><surname>Pessi</surname><given-names>A</given-names></name><name><surname>Daniele</surname><given-names>A</given-names></name><name><surname>Salvatore</surname><given-names>F</given-names></name><name><surname>Galdiero</surname><given-names>S</given-names></name></person-group><article-title>Design and activity of a cyclic mini-beta-defensin analog: a novel antimicrobial tool</article-title><source>Int J Nanomedicine</source><year>2015</year><volume>10</volume><fpage>6523</fpage><lpage>6539</lpage><?supplied-pmid 26508857?><pub-id pub-id-type="pmid">26508857</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie-Dyck</surname><given-names>S</given-names></name><name><surname>Kovacs-Nolan</surname><given-names>J</given-names></name><name><surname>Snider</surname><given-names>M</given-names></name></person-group><article-title>Babiuk LA, van Drunen Littel-van den Hurk S: inclusion of the bovine neutrophil beta-defensin 3 with glycoprotein D of bovine herpesvirus 1 in a DNA vaccine modulates immune responses of mice and cattle</article-title><source>Clin Vaccine Immunol</source><year>2014</year><volume>21</volume><fpage>463</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1128/CVI.00696-13</pub-id><?supplied-pmid 24451331?><pub-id pub-id-type="pmid">24451331</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mackenzie-Dyck</surname><given-names>S</given-names></name><name><surname>Latimer</surname><given-names>L</given-names></name><name><surname>Atanley</surname><given-names>E</given-names></name><name><surname>Kovacs-Nolan</surname><given-names>J</given-names></name><name><surname>Attah-Poku</surname><given-names>S</given-names></name><name><surname>Babiuk</surname><given-names>LA</given-names></name><name><surname>van Drunen Littel-van den Hurk</surname><given-names>S</given-names></name></person-group><article-title>Immunogenicity of a bovine herpesvirus 1 glycoprotein D DNA vaccine complexed with bovine neutrophil beta-defensin 3</article-title><source>Clin Vaccine Immunol</source><year>2015</year><volume>22</volume><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1128/CVI.00476-14</pub-id><?supplied-pmid 25378352?><pub-id pub-id-type="pmid">25378352</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crack</surname><given-names>LR</given-names></name><name><surname>Jones</surname><given-names>L</given-names></name><name><surname>Malavige</surname><given-names>GN</given-names></name><name><surname>Patel</surname><given-names>V</given-names></name><name><surname>Ogg</surname><given-names>GS</given-names></name></person-group><article-title>Human antimicrobial peptides LL-37 and human beta-defensin-2 reduce viral replication in keratinocytes infected with varicella zoster virus</article-title><source>Clin Exp Dermatol</source><year>2012</year><volume>37</volume><fpage>534</fpage><lpage>543</lpage><pub-id pub-id-type="doi">10.1111/j.1365-2230.2012.04305.x</pub-id><?supplied-pmid 22639919?><pub-id pub-id-type="pmid">22639919</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandt</surname><given-names>CR</given-names></name><name><surname>Akkarawongsa</surname><given-names>R</given-names></name><name><surname>Altmann</surname><given-names>S</given-names></name><name><surname>Jose</surname><given-names>G</given-names></name><name><surname>Kolb</surname><given-names>AW</given-names></name><name><surname>Waring</surname><given-names>AJ</given-names></name><name><surname>Lehrer</surname><given-names>RI</given-names></name></person-group><article-title>Evaluation of a theta-defensin in a murine model of herpes simplex virus type 1 keratitis</article-title><source>Invest Ophthalmol Vis Sci</source><year>2007</year><volume>48</volume><fpage>5118</fpage><lpage>5124</lpage><pub-id pub-id-type="doi">10.1167/iovs.07-0302</pub-id><?supplied-pmid 17962464?><pub-id pub-id-type="pmid">17962464</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yasin</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Pang</surname><given-names>M</given-names></name><name><surname>Cheshenko</surname><given-names>N</given-names></name><name><surname>Hong</surname><given-names>T</given-names></name><name><surname>Waring</surname><given-names>AJ</given-names></name><name><surname>Herold</surname><given-names>BC</given-names></name><name><surname>Wagar</surname><given-names>EA</given-names></name><name><surname>Lehrer</surname><given-names>RI</given-names></name></person-group><article-title>Theta defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry</article-title><source>J Virol</source><year>2004</year><volume>78</volume><fpage>5147</fpage><lpage>5156</lpage><pub-id pub-id-type="doi">10.1128/JVI.78.10.5147-5156.2004</pub-id><?supplied-pmid 15113897?><pub-id pub-id-type="pmid">15113897</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Fang</surname><given-names>L</given-names></name><name><surname>He</surname><given-names>Q</given-names></name><name><surname>Jin</surname><given-names>M</given-names></name><name><surname>Suo</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>M</given-names></name></person-group><article-title>Study on the isolation and identification of the Ea strain of pseudorabies virus</article-title><source>Acta Veterinaria et Zootechnica Sinica</source><year>1998</year><volume>29</volume><fpage>156</fpage><lpage>161</lpage></element-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reed</surname><given-names>LJ</given-names></name><name><surname>Muench</surname><given-names>H</given-names></name></person-group><article-title>A simple method of estimating fifty per cent endpoints12</article-title><source>Am J Epidemiol</source><year>1938</year><volume>27</volume><fpage>493</fpage><lpage>497</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a118408</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>SS</given-names></name><name><surname>Wiens</surname><given-names>ME</given-names></name><name><surname>Smith</surname><given-names>JG</given-names></name></person-group><article-title>Antiviral mechanisms of human defensins</article-title><source>J Mol Biol</source><year>2013</year><volume>425</volume><fpage>4965</fpage><lpage>4980</lpage><pub-id pub-id-type="doi">10.1016/j.jmb.2013.09.038</pub-id><?supplied-pmid 24095897?><pub-id pub-id-type="pmid">24095897</pub-id></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>M</given-names></name><name><surname>Keller</surname><given-names>MJ</given-names></name><name><surname>Fam</surname><given-names>EH</given-names></name><name><surname>Cheshenko</surname><given-names>N</given-names></name><name><surname>Hogarty</surname><given-names>K</given-names></name><name><surname>Kasowitz</surname><given-names>A</given-names></name><name><surname>Wallenstein</surname><given-names>S</given-names></name><name><surname>Carlucci</surname><given-names>MJ</given-names></name><name><surname>Tuyama</surname><given-names>AC</given-names></name><name><surname>Lu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Cervicovaginal secretions contribute to innate resistance to herpes simplex virus infection</article-title><source>J Infect Dis</source><year>2005</year><volume>192</volume><fpage>1731</fpage><lpage>1740</lpage><pub-id pub-id-type="doi">10.1086/497168</pub-id><?supplied-pmid 16235171?><pub-id pub-id-type="pmid">16235171</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>R</given-names></name><name><surname>Yu</surname><given-names>B</given-names></name><name><surname>Chen</surname><given-names>D</given-names></name></person-group><article-title>Different messenger RNA expression for the antimicrobial peptides beta-defensins between Meishan and crossbred pigs</article-title><source>Mol Biol Rep</source><year>2010</year><volume>37</volume><fpage>1633</fpage><lpage>1639</lpage><pub-id pub-id-type="doi">10.1007/s11033-009-9576-5</pub-id><?supplied-pmid 19466579?><pub-id pub-id-type="pmid">19466579</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Caruso</surname><given-names>C</given-names></name><name><surname>Vitale</surname><given-names>N</given-names></name><name><surname>Prato</surname><given-names>R</given-names></name><name><surname>Radaelli</surname><given-names>MC</given-names></name><name><surname>Zoppi</surname><given-names>S</given-names></name><name><surname>Possidente</surname><given-names>R</given-names></name><name><surname>Dondo</surname><given-names>A</given-names></name><name><surname>Chiavacci</surname><given-names>L</given-names></name><name><surname>Moreno Martin</surname><given-names>AM</given-names></name><name><surname>Masoero</surname><given-names>L</given-names></name></person-group><article-title>Pseudorabies virus in north-west Italian wild boar (Sus scrofa) populations: prevalence and risk factors to support a territorial risk-based surveillance</article-title><source>Vet Ital</source><year>2018</year><volume>54</volume><fpage>337</fpage><lpage>341</lpage><?supplied-pmid 30681133?><pub-id pub-id-type="pmid">30681133</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Minamiguchi</surname><given-names>K</given-names></name><name><surname>Kojima</surname><given-names>S</given-names></name><name><surname>Sakumoto</surname><given-names>K</given-names></name><name><surname>Kirisawa</surname><given-names>R</given-names></name></person-group><article-title>Isolation and molecular characterization of a variant of Chinese gC-genotype II pseudorabies virus from a hunting dog infected by biting a wild boar in Japan and its pathogenicity in a mouse model</article-title><source>Virus Genes</source><year>2019</year><volume>55</volume><fpage>322</fpage><lpage>331</lpage><pub-id pub-id-type="doi">10.1007/s11262-019-01659-x</pub-id><?supplied-pmid 30919175?><pub-id pub-id-type="pmid">30919175</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>T</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>W</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>Y</given-names></name></person-group><article-title>A competitive chemiluminescence enzyme immunoassay method for beta-defensin-2 detection in transgenic mice</article-title><source>Luminescence</source><year>2015</year><volume>30</volume><fpage>228</fpage><lpage>234</lpage><pub-id pub-id-type="doi">10.1002/bio.2718</pub-id><?supplied-pmid 24942821?><pub-id pub-id-type="pmid">24942821</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a-Valtanen</surname><given-names>P</given-names></name><name><surname>Martinez-Lopez</surname><given-names>A</given-names></name><name><surname>Ortega-Villaizan</surname><given-names>M</given-names></name><name><surname>Perez</surname><given-names>L</given-names></name><name><surname>Coll</surname><given-names>JM</given-names></name><name><surname>Estepa</surname><given-names>A</given-names></name></person-group><article-title>In addition to its antiviral and immunomodulatory properties, the zebrafish &#x003b2;-defensin 2 (zfBD2) is a potent viral DNA vaccine molecular adjuvant</article-title><source>Antivir Res</source><year>2014</year><volume>101</volume><fpage>136</fpage><lpage>147</lpage><pub-id pub-id-type="doi">10.1016/j.antiviral.2013.11.009</pub-id><?supplied-pmid 24286781?><pub-id pub-id-type="pmid">24286781</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vemula</surname><given-names>SV</given-names></name><name><surname>Amen</surname><given-names>O</given-names></name><name><surname>Katz</surname><given-names>JM</given-names></name><name><surname>Donis</surname><given-names>R</given-names></name><name><surname>Sambhara</surname><given-names>S</given-names></name><name><surname>Mittal</surname><given-names>SK</given-names></name></person-group><article-title>Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time</article-title><source>Virus Res</source><year>2013</year><volume>178</volume><fpage>398</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.virusres.2013.09.013</pub-id><?supplied-pmid 24051000?><pub-id pub-id-type="pmid">24051000</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Chu</surname><given-names>H</given-names></name><name><surname>Liu</surname><given-names>D</given-names></name><name><surname>Poon</surname><given-names>VK</given-names></name><name><surname>Chan</surname><given-names>CC</given-names></name><name><surname>Leung</surname><given-names>HC</given-names></name><name><surname>Fai</surname><given-names>N</given-names></name><name><surname>Lin</surname><given-names>YP</given-names></name><etal/></person-group><article-title>A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses</article-title><source>Sci Rep</source><year>2016</year><volume>6</volume><fpage>22008</fpage><pub-id pub-id-type="doi">10.1038/srep22008</pub-id><?supplied-pmid 26911565?><pub-id pub-id-type="pmid">26911565</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>R</given-names></name><name><surname>Luo</surname><given-names>L</given-names></name><name><surname>Mu</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>H</given-names></name><name><surname>Zou</surname><given-names>X</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name></person-group><article-title>Recombinant mouse &#x003b2;-Defensin 3 protects against Coxsackievirus B3-induced myocarditis in mice</article-title><source>Intervirology</source><year>2015</year><volume>58</volume><fpage>343</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1159/000442588</pub-id><?supplied-pmid 26829552?><pub-id pub-id-type="pmid">26829552</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>M</given-names></name></person-group><article-title>Antiviral activity of recombinant mouse &#x003b2;-defensin 3 against influenza a virus in vitro and in vivo</article-title><source>Antivir Chem Chemother</source><year>2012</year><volume>22</volume><fpage>255</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.3851/IMP2077</pub-id><?supplied-pmid 22345365?><pub-id pub-id-type="pmid">22345365</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>A</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Ivanova</surname><given-names>IV</given-names></name><name><surname>He</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Song</surname><given-names>W</given-names></name></person-group><article-title>High-level expression, purification and characterisation of porcine beta-defensin 2 in Pichia pastoris and its potential as a cost-efficient growth promoter in porcine feed</article-title><source>Appl Microbiol Biotechnol</source><year>2014</year><volume>98</volume><fpage>5487</fpage><lpage>5497</lpage><pub-id pub-id-type="doi">10.1007/s00253-014-5560-7</pub-id><?supplied-pmid 24515729?><pub-id pub-id-type="pmid">24515729</pub-id></element-citation></ref></ref-list></back></article>